This study used 1H MRS to measure and
compare brain GABA and glutamatergic compound (Glx) levels in
antipsychotic-nave schizophrenia patients during first-episode psychosis
(FEP) and age- and sex-matched healthy control (HC) subjects, and found
regional elevations or strong trend-level elevations of both
neurotransmitters in the FEP subjects.